From October 15 to 17, 2025, Xi’an Innov Biotechnology Co., Ltd. participated in Hi Japan 2025, held at Tokyo Big Sight, Japan’s leading international exhibition venue. As one of the most influential events in the Asian health and nutrition industry, Hi Japan brought together global experts, suppliers, and innovators in the fields of functional foods, dietary supplements, and health ingredients.
At Booth 1-191, Xi’an Innov showcased a wide range of premium nutritional ingredients, plant extracts, and functional raw materials, drawing the attention of numerous industry professionals. Our featured products — including liposomal formulations, antioxidant ingredients, and immune-boosting compounds — received particularly positive feedback from both new and long-term partners. Visitors showed strong interest in our liposomal technology, which improves ingredient bioavailability and enhances the efficacy of formulations for health and wellness products.
Throughout the three-day exhibition, our professional team engaged in in-depth discussions with global distributors, brand owners, and R&D specialists. These interactions not only strengthened existing partnerships but also opened the door to new cooperation opportunities. The exhibition also provided valuable insights into emerging market trends, such as clean-label innovation, natural ingredient sourcing, and sustainable manufacturing practices — all of which align with Xi’an Innov’s long-term development vision.
We are truly grateful to every visitor who stopped by our booth, exchanged ideas, and shared valuable feedback. The positive outcome of Hi Japan 2025 reinforces our mission to deliver high-quality, science-backed, and customer-driven solutions for the global nutraceutical industry.
With this fruitful journey behind us, Xi’an Innov Biotechnology looks forward to deepening collaborations, expanding international partnerships, and continuing to innovate for a healthier and more sustainable future.
See you again in Tokyo at Hi Japan 2026!
Let’s continue to grow together and shape the future of the global health industry.